| Jennifer Good | President and Chief Executive Officer | FY2025 | |
| James Cassella, Ph.D. | Chief Development Officer | FY2025 | |
| Farrell Simon, Pharm. D. | Chief Commercial Officer | FY2025 |
3 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.